Cerebrolysin
Also known as: FPF-1070
By GLPeptideSciences Editorial Team · How we evaluate evidence · Reviewed by Dr. George S. Watson, MD, Cardiothoracic Surgeon · Updated 2026-06-02
A mixture of low-molecular-weight neuropeptides and amino acids derived from pig brain, used clinically in some countries for stroke and dementia.
What it is & how it works
What it is
Cerebrolysin is a mixture of small neuropeptides and amino acids derived from porcine brain tissue, used as a neurotrophic agent in countries where it’s approved.
How it is thought to work
It’s proposed to mimic neurotrophic-factor activity, supporting neuronal survival and plasticity — the rationale for its use in stroke and dementia settings.
The evidence and the caveat
Unlike most peptides here it has real human trials and regional approval — but the independent evidence is mixed and debated, and it is not approved in the US.
What it's discussed & studied for
- Stroke recovery (regional clinical use)
- Dementia and cognition (regional clinical use)
Discussion of a use is not a claim that it works or is approved.
Research status
Approved and used in a number of countries; evidence is debated and it is not approved in the US. Reviews reach mixed conclusions.
Evidence quality
Has real human trials and regional approval, but meta-analyses are mixed and the effect sizes and trial quality are debated.
Dosing discussion
Administered as a course of injections in clinical settings where it's approved; no US-approved label.
Educational summary of what is discussed in the literature and community — not a dosing recommendation or medical advice.
Safety & harm reduction
Used clinically for decades in some regions with a generally tolerable profile; being a biological extract, it is unapproved in the US.
Sourcing literacy
A manufactured pharmaceutical where approved; material outside those channels is unverified.
Selected literature
FAQ
Is Cerebrolysin proven?
It's approved and used in several countries with real trials, but independent meta-analyses are mixed, and it's not approved in the US.